权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NICHD SERVICE: PRODUCT AGNOSTIC SUPPORT FOR ADVANCING MULTIPURPOSE PREVENTION TECHNOLOGIES

NICHD 服务：为推进多用途预防技术提供与产品无关的支持

基本信息

批准号：
10937100
负责人：
NA NA
金额：
$ 5万
依托单位：
PUBLIC HEALTH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-25 至 2024-09-24
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10937100
关键词：
Anti-Infective Agents Area Bacterial Vaginosis Chlamydia Clinical Clinical Trials Design Communicable Diseases Consultations Contraceptive Agents Contraceptive methods Contractor Contracts Data Development Development Plans Ensure Ethics Experimental Designs Extramural Activities Funding Government Grant HIV HIV/AIDS Methods Monitor National Institute of Child Health and Human Development Pharmacology Phase Phase I Clinical Trials Policies Pregnancy Prevention Procedures Program Development Property Protocols documentation Recommendation Reporting Reproductive Health Research Research Personnel Risk Assessment Safety Services Sexual Health Sexually Transmitted Diseases Techniques Technology Toxicology U-Series Cooperative Agreements Woman Work design drug development experience good laboratory practice meetings men participant safety pathogen pre-clinical preclinical development prevent product development reproductive research facility virology

项目摘要

The NICHD Contraception Research Branch (CRB) is conducting research related to developing contraceptives technologies with anti-infective properties against pathogens such as HIV, Bacterial Vaginosis, Chlamydia, etc. The objective of the order request is to obtain preclinical and/or clinical (e.g., Phase 1) multipurpose prevent technologies (MPT, contraceptives with anti-infective properties: e.g., anti-HIV) related consulting services for a range of product development considerations. This includes developing contraceptives technologies with anti-infective properties against pathogens such as HIV, Bacterial Vaginosis, Chlamydia, etc. supported by NICHD’s Contraception Research Branch. These services shall provide expert consultation to NICHD staff on pre-clinical, Phase 1 clinical, ethical, policy, and regulatory issues related to NICHD’s extramural contraceptive research portfolio and other related product development related areas, as directed by NICHD staff.

NICHD避孕研究处(CRB)正在进行与开发具有抗艾滋病毒、细菌性阴道病、衣原体等病原体的感染性能的避孕技术有关的研究。订购申请的目的是获得临床前和/或临床(例如，第一阶段)多用途预防技术(MPT，具有抗感染特性的避孕药：例如，抗HIV)相关的咨询服务，以满足一系列产品开发考虑。这包括开发具有抗感染性能的避孕技术，以对抗艾滋病毒、细菌性阴道病、衣原体等病原体，并得到NICHD避孕研究处的支持。这些服务将在NICHD工作人员的指导下，就与NICHD的外部避孕研究组合和其他相关产品开发相关的临床前、第一阶段临床、伦理、政策和监管问题向NICHD工作人员提供专家咨询。